Cefovit Forte

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Cefovit Forte

Cefovit Forte is a prescription-only medication that belongs to the class of antibiotics. Its general purpose is to fight and eliminate infections caused by susceptible bacteria throughout the body. The medicine is ineffective against viral illnesses like the common cold or flu.

Property Description
Active Ingredient Cephalexin (or Cephalexin Monohydrate)
Route of Administration Oral (by mouth)
Forms Capsule, Tablet, Powder for oral suspension
Pharmacological Class First-Generation Cephalosporin Antibiotic
Origin Semisynthetic

What Type of Antibiotic is Cefovit Forte? (Identity and Classification)

The therapeutic action of Cefovit Forte is delivered by its active ingredient, cephalexin, which is classified as a first-generation cephalosporin. Cephalosporins are part of the larger beta-lactam family of antibiotics, sharing a core chemical structure that allows them to kill bacteria. The specific brand Cefovit Forte is manufactured by Rekah Pharmaceutical Industries and is primarily marketed in Israel, where it is dispensed exclusively with a doctor's prescription.

This agent is semisynthetic, meaning it is chemically derived from a natural substance to maximize its effectiveness. The drug's action, which involves inhibiting bacterial cell wall synthesis, is clinically recognized for its effectiveness against common Gram-positive and specific Gram-negative organisms, supporting its established use in various patient groups.


Composition and Available Forms of Cephalexin

Cefovit Forte is a single-active ingredient product containing only cephalexin monohydrate as the therapeutic substance. This compound is administered by the oral route and is commonly available in several forms to suit patient needs.

These forms include the solid oral capsule and tablet, as well as a powder for oral suspension which is reconstituted into a liquid medicine. The drug's properties demonstrate its effectiveness when given by mouth, noting that it is rapidly absorbed after oral administration. This high rate of absorption is a key reason cephalexin is a reliable choice for treating susceptible infections outside of hospital settings.

Regulatory References

  1. Cephalexin (MedlinePlus)

What side effects are possible with Cefovit Forte?

Possible Side Effects and Safety Information

The safety profile of Cefovit Forte is officially documented according to standardized regulatory classifications, which organize potential adverse reactions by frequency and the body system affected. All documented effects are derived from regulatory prescribing information.

Frequency-Classified Adverse Reactions

The most commonly listed adverse reactions are typically gastrointestinal disorders.

Classification Examples of Officially Documented Effects
Common (1 to 10 in 100) Diarrhea, Nausea.
Uncommon (1 to 10 in 1,000) Skin rash, Urticaria (hives), Eosinophilia (changes in blood cell counts).
Rare (1 to 10 in 10,000) Pseudomembranous colitis, Anaphylactic reactions, Reversible interstitial nephritis (kidney disorder), Hemolytic anemia, Seizures, Dizziness.

System-Organ Classes and Serious Events

Adverse effects are documented across various systems, including Gastrointestinal Disorders, Immune System Disorders, Nervous System Disorders, and Renal and Urinary Disorders. The official labeling explicitly notes the potential for serious adverse reactions, although these are rare. These include Anaphylaxis and other severe allergic reactions (such as Stevens-Johnson Syndrome), potentially life-threatening Pseudomembranous Colitis (Clostridium difficile-associated diarrhea or CDAD), and neurotoxicity including the risk of seizures.

Safety Considerations and Limitations

The medicine is contraindicated in patients with a history of allergy to cephalexin or any other cephalosporin antibiotic. Caution is advised for patients with impaired renal function, as reduced kidney clearance may increase drug accumulation and the risk of adverse effects, requiring clinical observation. Furthermore, official safety notes indicate that prolonged use may lead to the overgrowth of non-susceptible organisms, and that CDAD may manifest up to two months after the medicine is discontinued. The drug may also cause a false-positive reaction for glucose in the urine with specific testing methods.

Overdose and Emergency Response

Cefovit Forte Overdose and when to seek help

An overdose of Cefovit Forte (Cephalexin) is officially documented by regulatory authorities. The profile establishes that excessive ingestion primarily presents with specific clinical gastrointestinal manifestations, including nausea, vomiting, diarrhea, and epigastric distress. A key physiological finding noted is haematuria, which may be described as pink, red, or dark brown urine.

Immediate medical attention is strictly mandated. Emergency services must be contacted for severe outcomes like collapse, seizure, trouble breathing, or if the person cannot be awakened. These scenarios are classified by regulators as potentially life-threatening symptoms requiring urgent intervention.

Official management following emergency action centers on instituting general supportive measures and providing symptomatic care. Close clinical and laboratory monitoring is required, focusing on haematological, hepatic, and renal functions, and coagulation status. Patients with impaired renal function are specifically noted to have an increased risk of toxic reactions due to delayed drug clearance. Furthermore, regulatory sources confirm that the benefit of specific removal procedures, such as haemodialysis, has not been established in this context.

Therapeutic Uses of Cefovit Forte

What Cefovit Forte Treats: Main Uses and Benefits

Symptom Relief Across Key Domains

The therapeutic scope of Cefovit Forte is relevant for managing symptoms associated with susceptible bacterial infections. This relevance extends to contexts marked by increased discomfort or tension, commonly applied in conditions involving infections of the respiratory tract, urinary tract, and skin and soft tissues.

Cefovit Forte is used for managing symptom clusters that may become intense or disruptive, such as fever, pain, redness, swelling, and discomfort associated with acute episodes. The medication is considered relevant for conditions like bacterial bronchitis, middle ear infections, strep throat, and uncomplicated urinary tract infections (UTIs).

In these situations, the general benefit is that the medication provides support that helps ease the overall symptom burden and assists with maintaining functional stability. This assistance is particularly valuable during acute phases when symptoms become more noticeable, helping patients cope more steadily with temporary physiological imbalance.

Quick Fact: Relief for Symptoms that Interfere with Functioning
Cefovit Forte is relevant for easing symptoms related to inflammatory or irritative states caused by bacteria, especially when these symptoms create noticeable functional strain or discomfort.

As a patient-oriented summary:

“Cefovit Forte is intended to offer symptomatic relief and supportive care against the bacteria causing your current infection.”

Regulatory References

  1. NIH DailyMed information on Cefixime

Eligibility and Restrictions for Use

Eligibility Map: Who Can and Cannot Use Cefovit Forte

Cefovit Forte (Cephalexin) use is determined by official population-eligibility rules established by governmental regulatory authorities.


Contraindications and Restrictions

Category Regulatory Rule Status
Cephalosporin/Cephalexin Allergy Patients with a known hypersensitivity to the drug or the cephalosporin class are absolutely prohibited from use. CONTRAINDICATED
Age Restriction Safety and effectiveness are established in children over one year of age. Use in children younger than 1 year must be determined by a physician. RESTRICTED
Renal Function Use in patients with markedly impaired renal function (creatinine clearance < 30 mL/min) requires caution and careful clinical oversight. CONDITIONAL
Pregnancy/Lactation Use in pregnant women is not recommended unless clearly needed. Nursing mothers must use the drug with caution as it is excreted into human milk. CONDITIONAL
Penicillin Allergy Patients with a extbfhistory of penicillin allergy must use the drug with extbfcaution due to documented cross-hypersensitivity risk. CAUTION

These constraints ensure that eligibility is strictly defined based on regulatory guidance regarding patient safety and established use profiles.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official regulatory profile for Cefovit Forte (Cephalexin) details specific drug-drug, drug-supplement, and diagnostic test interactions that necessitate restrictions on co-administration. These findings are based strictly on authoritative governmental drug labels.

Pharmacokinetic and Pharmacodynamic Restrictions

Interacting Substance Official Regulatory Restriction Interaction Type
Probenecid Co-administration is not recommended. Pharmacokinetic (Inhibition of Renal Excretion)
Warfarin Use requires caution due to potential increased risk of bleeding. Pharmacodynamic (Coagulation Effect)
Zinc Supplements Must be separated by 3 hours to prevent reduced absorption. Absorption Interference

Official Interaction Statements

Regulatory documents explicitly describe the following interaction patterns:

  • The co-administration of Probenecid inhibits the renal excretion of cephalexin, leading to increased plasma concentrations of Cefovit Forte.
  • Cephalexin also interacts with Metformin, resulting in increased Metformin plasma concentrations and decreased Metformin renal clearance.
  • For patients taking Warfarin or related anticoagulants, co-administration may cause reduced prothrombin activity and prolongation of the prothrombin time.
  • The risk of prolonged prothrombin time during co-administration with anticoagulants is specifically noted to be more significant in populations with existing renal or liver dysfunction.
  • Zinc-containing supplements reduce the oral absorption of Cefovit Forte, necessitating the 3-hour separation rule.
  • Cefovit Forte may cause a false-positive reaction for glucose in the urine when tested using specific testing solutions, such as Benedict’s or Fehling’s solution.

Mechanism of Action

Cefovit Forte (a cephalosporin) exerts its effect by targeting the essential structures of susceptible bacteria. This action is described as bactericidal, reflecting a mechanism that disrupts cell viability.

Inhibition of Cell Wall Synthesis

This mechanistic domain describes how the drug disrupts bacterial survival. Cefovit Forte targets enzymes responsible for constructing the bacterial peptidoglycan layer, which is required for structural integrity.

Binding to Penicillin-Binding Proteins (PBPs)

The drug's activity centers on its ability to covalently and irreversibly bind to specific Penicillin-Binding Proteins (PBPs). These transpeptidases catalyze the final cross-linking step of peptidoglycan synthesis. By mimicking the PBP substrate, the drug competitively inhibits this enzymatic process.

Loss of Structural Integrity and Cell Lysis

This mechanistic cascade describes the resulting physiological effects following target inhibition. The blocked cross-linking reduces the structural rigidity of the bacterial cell wall, which can activate autolytic enzymes within the cell. This cascade leads to osmotic instability and ultimately results in the rupture of the bacterial organism, completing the mechanistic cascade.

Dosage and Administration Information

Cefovit Forte is administered strictly via the oral route (by mouth) and is available in dosage forms including capsules, tablets, and a powder for oral suspension.


Standard Dosing and Scheduling

The medicine is typically administered in two or four equally divided doses throughout the day. Doses should be spaced as evenly as possible. The adult dosing range for a day is usually 1 gram to 4 grams, with the most common regimens being 250 mg every 6 hours or 500 mg every 12 hours. For severe infections, the total daily dose can be increased up to the maximum of 4 grams.

Population Dosing Rule Maximum Daily Dose
Adults (General) 250 mg every 6 hours or 500 mg every 12 hours 4 grams
Pediatric (by weight) 25 to 50 mg/kg/day, divided into doses 4 grams

Administration Conditions and Duration

Cefovit Forte may be taken with or without food as it is acid-stable. The powder for oral suspension must be reconstituted and shaken thoroughly before measuring each dose. If a dose is missed, it should be taken as soon as remembered, unless it is almost time for the next scheduled dose, in which case the missed dose should be skipped.

Duration of therapy typically ranges from 7 to 14 days. However, for infections caused by beta-hemolytic streptococci, treatment must be continued for a minimum of 10 days.

Population Adjustments

Dosage modification is required in the presence of marked renal impairment (e.g., Creatinine Clearance <30 mL/min) to prevent drug accumulation, as the medicine is primarily excreted by the kidneys. Older adult patients should be monitored for age-related decline in renal function.

Recent Clinical Evidence

Research evidence / Overview of Studies for Cefovit Forte

Evidence for Acute Bacterial Infections

The use of Cefovit Forte (cephalexin) has been evaluated across three main infection categories through clinical trials and regulatory reviews.

For Skin and Soft Tissue Infections (SSTI), researchers conducted short-term Randomized Controlled Trials (RCTs) exploring measured changes in outcomes related to physical discomfort and systemic imbalance in outpatient adults and children. Findings describe patterns observed in these studies where clinical cure, defined by symptom resolution, was observed in some treated patients. The results apply only to the populations studied, and evidence remains limited for infections involving Methicillin-Resistant S. aureus (MRSA).

For Respiratory and Middle Ear Infections, the evidence base includes early comparative clinical trials monitoring microbiological clearance and clinical response in adults and pediatric patients. Research for streptococcal pharyngitis is supported by a large volume of available data. Studies on acute otitis media described mixed findings, citing potential rates of treatment failure when compared to other antibiotics for specific bacteria.

For Urinary Tract Infections (UTI) and Bone Infections, Cefovit Forte was evaluated in clinical trials for uncomplicated UTIs, monitoring microbiological cure. For bone infections, research describes its use as a sequential oral follow-up to initial intravenous therapy in selected groups. Data are still emerging regarding its role against modern, resistant Gram-negative bacteria often linked to UTIs.

Overall, the research has explored both pediatric patients and adults, but comparative evidence is lacking for patients with complex comorbidities. Follow-up durations were typically limited to the acute phase, meaning long-term effects regarding relapse or recurrence are not fully established.

Key Studies & References

  1. Cephalexin Monograph: Clinical Pharmacology and Indications

Frequently Asked Questions (FAQ)

Common questions about Cefovit Forte (FAQ)


Q: Does Cefovit Forte help with pain and fever, or just the infection?

A: Cefovit Forte is an antibiotic, and its primary purpose is to stop the growth and spread of bacteria to treat an infection. Official regulatory information describes its action as bactericidal, meaning it kills the bacteria causing the illness. It is not an analgesic (pain reliever) or an antipyretic (fever reducer) and is not intended to treat pain or fever directly.

Q: I'm taking vitamins; can Cefovit Forte interact with them?

A: Regulatory documents indicate a specific interaction with Zinc-containing supplements. To maintain the medicine’s effectiveness, supplements containing zinc must be separated from the Cefovit Forte dose by at least three hours. Official information does not specify critical interactions with most standard multivitamins, but standard professional practice involves full disclosure of all supplements to the prescribing professional.

Q: Does Cefovit Forte cause unusual changes in urine or stool color?

A: Unusual changes in stool color are not typically listed among the commonly reported side effects. However, official information notes that in rare instances of a severe reaction or overdose, urine may appear pink, red, or dark brown due to blood. The medicine may be associated with a false-positive reaction for glucose when the urine is tested using certain solutions.

Q: Can Cefovit Forte make me feel tired or drowsy?

A: Yes, regulatory documentation reports that fatigue (extreme tiredness) can be a commonly reported side effect of Cefovit Forte. Additionally, less common side effects include dizziness. Since these effects are reported, caution is generally indicated until a person is aware of how the medicine affects them.

Q: How quickly should I expect to see an improvement after starting Cefovit Forte?

A: According to official guidelines, patients generally begin to feel better or see an improvement in symptoms during the first few days of treatment. It is important to remember that the full course of medicine must be completed, even if improvement is noted quickly. If symptoms do not improve or worsen after a few days, this situation is generally considered a signal to seek guidance from a qualified health professional.

Q: Is Cefovit Forte a penicillin-type drug?

A: No, Cefovit Forte (cephalexin) is officially classified as a cephalosporin antibiotic, which is a separate class from penicillins. However, official safety documentation advises caution because there can be cross-hypersensitivity (an allergic reaction risk) between cephalosporins and penicillins in some patients.

Q: Can Cefovit Forte affect my ability to drive?

A: In rare instances, Cefovit Forte can cause side effects that may potentially impact your coordination or alertness. The official safety information lists potential effects such as dizziness or confusion. Due to the potential for these effects, official information suggests that caution is warranted before performing activities that require full mental alertness.

Q: I forgot to take one dose; does that stop the drug from working?

A: Forgetting one dose does not stop the overall therapeutic course from working, but the course must be completed as prescribed to achieve the intended effect. The specific steps for handling a missed dose are detailed in the official prescribing instructions, which are separate from this FAQ.

Q: Is Cefovit Forte known to cause issues with sleep?

A: Disorders of sleep are not listed as a primary side effect in official reports. However, Cefovit Forte is known to commonly cause fatigue, and it may rarely be associated with effects such as agitation or confusion. These reported effects could potentially interfere with a person’s typical sleep routine.

Q: Does Cefovit Forte make birth control pills less effective?

A: Official labeling does not explicitly state that Cefovit Forte reduces the effect of oral contraceptives. However, one common side effect of Cefovit Forte is diarrhea, which, if severe, can affect the absorption and effectiveness of birth control pills. If severe digestive upset occurs, it may necessitate a consultation with a healthcare professional regarding temporary use of additional non-hormonal birth control methods.

Q: Can Cefovit Forte interact with herbal supplements like St. John's Wort?

A: Official drug sources caution that there is not enough reliable information to confirm the safety of taking Cefovit Forte with most herbal remedies, including St. John’s Wort. It is generally advised to separate the use of complementary and herbal medicines from prescription drugs. For all herbal and prescription medicines, official guidelines support full disclosure to the treating professional.

Q: Does Cefovit Forte interact with common over-the-counter painkillers?

A: Official documents list specific interactions with certain prescription drugs like Metformin and Warfarin. Common over-the-counter analgesics, such as acetaminophen or ibuprofen, are not typically listed as having major interactions, but standard medical practice requires full disclosure of all medicines to the prescribing professional.

Q: Are there different strengths or versions of Cefovit Forte available?

A: Yes, official regulatory documents list Cefovit Forte (cephalexin) as being available in multiple strengths and forms. These include capsules or tablets in strengths such as 250 mg, 333 mg, 500 mg, and 750 mg, and it is also available as a powder for oral suspension.

Q: Does Cefovit Forte commonly cause headaches?

A: Yes, official reports of adverse reactions indicate that headache is listed among the possible side effects reported with the use of Cefovit Forte. This is one of several non-gastrointestinal reactions that may occur while taking the medicine.

Q: Do studies suggest Cefovit Forte is safe for older adults?

A: Clinical trials generally found the effectiveness and safety profile in older adults to be similar to that in younger adults. However, official prescribing information advises monitoring geriatric patients because age-related decline in kidney function may require adjusting the dose. This monitoring helps prevent drug accumulation in the body.

Q: Is Cefovit Forte ever used in hospital settings?

A: Yes, official regulatory information acknowledges its role in certain treatment plans. For instance, in treating bone infections, Cefovit Forte is noted for its use as a sequential oral follow-up to an initial intravenous (IV) therapy given in a hospital setting.

Q: Is it true that Cefovit Forte can cause yeast infections?

A: Yes, vaginal yeast infections (candidiasis) and oral thrush (yeast infection in the mouth) have been reported as possible side effects. Antibiotics can sometimes lead to the overgrowth of non-susceptible organisms like yeast, which normally thrive when competing bacteria are eliminated.

Q: Can I take Cefovit Forte if I have a known allergy to other antibiotics?

A: Caution is advised. The medicine is contraindicated if a person has an allergy to cephalexin or any other drug in the cephalosporin class. Furthermore, official safety warnings mention the possibility of cross-hypersensitivity among beta-lactam antibiotics. Full disclosure of all known drug allergies to the prescribing professional is a mandatory step in the clinical process.

Q: Does the efficacy of Cefovit Forte change over the course of treatment?

A: The medicine's efficacy (its ability to work) is maintained throughout the course when taken as prescribed. However, the prolonged use of Cefovit Forte carries a risk noted in official documents for the development of drug-resistant bacteria. If the infection is caused by non-susceptible bacteria, the drug may be ineffective.

Q: Is Cefovit Forte considered a 'broad-spectrum' drug?

A: Cefovit Forte (cephalexin) is classified as a first-generation cephalosporin. Official information defines its spectrum of activity as being effective against a range of Gram-positive bacteria and a more limited range of Gram-negative bacteria. This classification dictates its use in treating susceptible organisms for various infections.

Q: What are the general guidelines about taking Cefovit Forte during pregnancy?

A: Official regulatory documents classify Cefovit Forte in FDA Pregnancy Category B, which is based on animal studies showing no harm to the fetus. The medicine is generally regarded as compatible with pregnancy, but the decision for use is a clinical one, requiring an individualized risk-benefit assessment by a healthcare provider.

Q: Can Cefovit Forte affect the results of blood tests?

A: Yes, official safety information indicates that Cefovit Forte can cause a positive direct Coombs' test result, which is used to detect certain blood conditions. In rare cases, it may also be associated with a prolonged prothrombin time (a measure of how quickly blood clots), particularly in patients also taking anticoagulants.

Q: What does the research say about Cefovit Forte's use in combination therapies?

A: Research and regulatory evidence notes the medicine's role in sequential therapy rather than typical combination use. For specific infections, such as bone infections, Cefovit Forte may be used as an oral treatment that follows an initial course of intravenous (IV) antibiotics.

Q: Does Cefovit Forte cause sensitivity to sunlight?

A: No, clinical guidelines and regulatory review documents consistently state that Cefovit Forte does not cause photosensitivity. This means it is not associated with an increased sensitivity to sunlight exposure, which can be a risk with some other classes of antibiotics.

Q: How long does Cefovit Forte stay in the system after the last dose?

A: For individuals with normal kidney function, the official clinical pharmacology information indicates that the elimination half-life is short, typically ranging from 0.6 to 1.2 hours. This half-life is the time it takes for half of the dose to be cleared from the system.

Q: Does Cefovit Forte interact with medication for high blood pressure?

A: Official labeling does not consistently associate the medicine with major interactions with the most common high blood pressure drugs. However, because Cefovit Forte is primarily excreted by the kidneys, warnings apply to patients taking diuretics (water pills) or other drugs that impact renal function, and such conditions may necessitate specific clinical observation or supervision.

Q: Is it possible to develop a tolerance to Cefovit Forte over time?

A: The medicine does not cause physical tolerance or dependence in the traditional sense. However, official warnings caution that prolonged use can increase the risk of the development of drug-resistant bacteria. This is a risk that could eventually render the medicine ineffective against future infections.

How should Cefovit Forte be stored and disposed of?

How to Store and Dispose of Cefovit Forte?

Cefovit Forte (Cephalexin) storage is determined by its form. All forms must be kept out of the reach of children and protected from light and moisture in a tightly closed container.


Mandatory Storage Conditions

Form Temperature Requirement
Capsules/Tablets/Dry Powder Controlled room temperature (20 C to 25 C)
Reconstituted Oral Suspension Refrigerated (2 C to 8 C); Do not freeze

Stability and Disposal

The reconstituted liquid suspension is stable for a maximum of 14 days when refrigerated and must be discarded after this period. Unused or expired medication should be disposed of according to local regulations and official guidance. Patients should consult a pharmacist on disposal methods and are usually advised not to flush the medication down the toilet.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Cefovit Forte found in:

A-Z Index: